By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

XBiotech USA, Inc. 

8201 E Riverside Drive
Building 4, Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-386-5107 Fax: n/a


SEARCH JOBS



Segment
Start Up





Company News
Xbiotech Advances Phase I/II Clinical Study Of Novel True Human Therapeutic Antibody For Treating Serious Infections Due To Staphylococcus Aureus 9/1/2015 7:23:27 AM
Xbiotech Completes Enrollment For Xilonix Phase III Registration Study In Europe 8/17/2015 5:59:38 AM
XBiotech USA (XBIT) Announces Expansion Of Global Phase III Registration Study In Europe Using Xilonix For Treatment Of Metastatic Colorectal Cancer 8/7/2015 8:19:33 AM
XBiotech USA (XBIT) Provides Second Quarter 2015 Corporate And Clinical Update 7/28/2015 7:54:12 AM
XBiotech USA (XBIT) To Provide Second Quarter Business Update 7/15/2015 7:54:00 AM
XBiotech USA (XBIT) Announces Publication Of Clinical Results Supporting Its True Human Antibody Therapy For Type 2 Diabetes Mellitus 7/7/2015 7:03:31 AM
XBiotech USA (XBIT) Treats First Patient In Phase I/II Clinical Study Of Novel True Human Therapeutic Antibody For Treating Serious Infections Due To Staphylococcus Aureus 7/6/2015 6:56:42 AM
XBiotech USA (XBIT) Conducts Investigators Meeting To Update The Status Of Its Phase III Registration Study Underway In Europe 7/1/2015 7:12:52 AM
XBiotech USA (XBIT) Announces Publication Of Phase II Clinical Results For Its True Human Antibody Mabp1 For Treating Acne Vulgaris 6/15/2015 9:02:34 AM
XBiotech USA (XBIT) Appoints Kelly R. Thornburg As Senior Vice President Of Operations 6/8/2015 8:03:43 AM
1234
//-->